1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > In Vitro Diagnostics Market Trends
  5. > Russia Infectious Diagnostics Market Outlook to 2021

Russia Infectious Diagnostics Market Outlook to 2021

  • October 2015
  • -
  • Global Data
  • -
  • 36 pages

Russia Infectious Diagnostics Market Outlook to 2021

Summary

GlobalData’s new report, "Russia Infectious Diagnostics Market Outlook to 2021", provides key market data on the Russia Infectious Diagnostics market. The report provides value, in millions of US dollars within market segments - Hepatitis Viruses, Retroviruses, Infectious Diagnostics Multiple Parameters Panels, Bacteriology, Nucleic Acid Testing Instruments, Other Virology, Infectious Diagnostics Rapid Tests & POC and Parasitology & Mycology.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Infectious Diagnostics market includes Hepatitis Viruses, Retroviruses, Infectious Diagnostics Multiple Parameters Panels, Bacteriology, Nucleic Acid Testing Instruments, Other Virology, Infectious Diagnostics Rapid Tests & POC and Parasitology & Mycology.
- Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
- 2014 company shares and distribution shares data for Infectious Diagnostics market.
- Global corporate-level profiles of key companies operating within the Russia Infectious Diagnostics market.
- Key players covered include Siemens Healthcare, F. Hoffmann-La Roche Ltd., Abbott Laboratories, Hologic, Inc., Qiagen N.V., Becton, Dickinson and Company, Danaher Corporation and Alere Inc..

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.

Table Of Contents

Russia Infectious Diagnostics Market Outlook to 2021
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 3
1.2 List of Figures 3
2 Introduction 4
2.1 What Is This Report About? 4
2.2 Infectious Diagnostics Market Segmentation 4
2.3 Definitions of Markets Covered in the Report 5
3 Infectious Diagnostics Market, Russia 7
3.1 Infectious Diagnostics Market, Russia, Revenue ($m), 2007-2014 7
3.2 Infectious Diagnostics Market, Russia, Revenue ($m), 2014-2021 9
3.2.1 Infectious Diagnostics Rapid Tests and POC Market, Russia, Revenue ($m), by Segment, 2007-2014 11
3.2.2 Infectious Diagnostics Rapid Tests and POC Market, Russia, Revenue ($m), by Segment, 2014-2021 13
3.3 Infectious Diagnostics Market, Russia, Distribution Share by Revenue ($m), 2013-2014 15
3.4 Infectious Diagnostics Market, Russia, Company Share by Revenue ($m), 2014 16
4 Overview of Key Companies in Russia, Infectious Diagnostics Market 18
4.1 F. Hoffmann-La Roche Ltd. 18
4.1.1 Company Overview 18
4.2 Siemens Healthcare 18
4.2.1 Company Overview 18
4.3 Abbott Laboratories 18
4.3.1 Company Overview 18
4.4 bioMerieux S.A. 19
4.4.1 Company Overview 19
4.5 Danaher Corporation 19
4.5.1 Company Overview 19
5 Infectious Diagnostics Market Pipeline Products 20
6 Financial Deals Landscape 32
6.1 Partnerships 32
6.1.1 Biocartis Enters into Licensing and Development Agreement with Microbiome 32
7 Appendix 33
7.1 Research Methodology 34
7.1.1 Coverage 34
7.1.2 Secondary Research 34
7.1.3 Primary Research 34
7.1.4 Company Share Analysis 35
7.1.5 Distribution Share Analysis 35
7.2 GlobalData Consulting 35
7.3 Contact Us 35
7.4 Disclaimer 36

1.1 List of Tables
Table 1: Infectious Diagnostics Market, Russia, Revenue ($m), USD Constant, Historic, 2007-2014 8
Table 2: Infectious Diagnostics Market, Russia, Revenue ($m), USD Constant, Forecast, 2014-2021 10
Table 3: Infectious Diagnostics Rapid Tests and POC Market, Russia, Revenue ($m), USD Constant, Historic, 2007-2014 12
Table 4: Infectious Diagnostics Rapid Tests and POC Market, Russia, Revenue ($m), USD Constant, Forecast, 2014-2021 14
Table 5: Infectious Diagnostics Market, Russia, Distribution Share by Revenue ($m), USD Constant, 2013-2014 15
Table 6: Infectious Diagnostics Market, Russia, Company Share by Revenue ($m), USD Constant, 2014 17
Table 7: Infectious Diagnostics Market Pipeline Products 20
Table 8: Biocartis Enters into Licensing and Development Agreement with Microbiome 32

1.2 List of Figures
Figure 1: Infectious Diagnostics Market, Russia, Revenue ($m), USD Constant, Historic, 2007-2014 7
Figure 2: Infectious Diagnostics Market, Russia, Revenue ($m), USD Constant, Forecast, 2014-2021 9
Figure 3: Infectious Diagnostics Rapid Tests and POC Market, Russia, Revenue ($m), USD Constant, Historic, 2007-2014 11
Figure 4: Infectious Diagnostics Rapid Tests and POC Market, Russia, Revenue ($m), USD Constant, Forecast, 2014-2021 13
Figure 5: Infectious Diagnostics Market, Russia, Company Share (%) 2014 16

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Immunoassay Market by Product & Service, Technique, Application, End User - Global Forecast to 2021

Immunoassay Market by Product & Service, Technique, Application, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • November 2016
  • by MarketsandMarkets

The immunoassay market is expected to reach USD 25.45 billion by 2021 from USD 17.16 billion in 2016 at a CAGR of 8.2%. The global immunoassay market is segmented based on product & service, technology, ...

Point of Care Diagnostics, BCC Research

Point of Care Diagnostics, BCC Research

  • $ 6650
  • Industry report
  • November 2016
  • by BCC Research

Use this report to: - Review business opportunities in the thriving near-patient testing market. - Learn about the impact of chronic diseases, growing and aging populations. - Receive information about ...

Global POC Pregnancy & Fertility Testing Market Analysis & Trends - Test Type ((hCG) Urine Test, FSH Urine Test, (hCG) Blood Test & (LH) Urine Test), Product, Distribution Channels - Forecast to 2025

Global POC Pregnancy & Fertility Testing Market Analysis & Trends - Test Type ((hCG) Urine Test, FSH Urine Test, (hCG) Blood Test & (LH) Urine Test), Product, Distribution Channels - Forecast to 2025

  • $ 4200
  • Industry report
  • November 2016
  • by Accuray Research LLP

The Global POC Pregnancy and Fertility Testing Market is poised to grow at a CAGR of around XX% over the next decade to reach approximately $XX million by 2025. Some of the prominent trends that the market ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.